TY - JOUR
T1 - Opioid use in the postpartum period
T2 - Are we prescribing too much?
AU - Prentice, Danielle
AU - Berry, Amanda
AU - Stewart, Linzi
AU - Wilkins, Heather
AU - Ural, Serdar
AU - Deiter, Raymond
N1 - Publisher Copyright:
© 2020 American Osteopathic Association.
PY - 2020/10
Y1 - 2020/10
N2 - Context: The first exposure to opioids for many women of reproductive age follows childbirth. Current data show a significant correlation between the number of days supplied and continued use/abuse of opioids. The number of women with opioid dependency in pregnancy is steadily increasing, and opioid use is directly linked to an increase in maternal and neonatal morbidity and mortality. However, there are no clear opioid-prescribing guidelines for the postpartum period. Objective: To compare the number of opioid pills prescribed with the number used by patients in the postpartum period. Methods: Patients were recruited to this pilot study at the time of admission to the labor and delivery unit at a community hospital in Oklahoma City, Oklahoma; 84 patients gave informed consent to participate. Medical records were reviewed to determine the number of opioids prescribed. Phone surveys were conducted 4 to 6 weeks after discharge to identify the number of opioids used during the postpartum period. Welch t test was used to determine P values. Results: After exclusion criteria were applied, records of 23 patients with vaginal deliveries and 14 patients with cesarean sections were included in the study. Patients who were prescribed opioids after a vaginal delivery were prescribed signifi-cantly more pills than were used (P<.001); a mean of 10 opioid pills per patient remained unused. Patients prescribed opioids after cesarean section were also often prescribed more opioid pills than used (P<.05); a mean of 7.5 opioid pills per patient remained unused. Of 37 patients, only 2 disposed of unused opioid pills. Conclusion: The data in this study show a clear example of overprescribing opioids after vaginal and cesarean deliveries leading to increased opioid pill availability within the community.
AB - Context: The first exposure to opioids for many women of reproductive age follows childbirth. Current data show a significant correlation between the number of days supplied and continued use/abuse of opioids. The number of women with opioid dependency in pregnancy is steadily increasing, and opioid use is directly linked to an increase in maternal and neonatal morbidity and mortality. However, there are no clear opioid-prescribing guidelines for the postpartum period. Objective: To compare the number of opioid pills prescribed with the number used by patients in the postpartum period. Methods: Patients were recruited to this pilot study at the time of admission to the labor and delivery unit at a community hospital in Oklahoma City, Oklahoma; 84 patients gave informed consent to participate. Medical records were reviewed to determine the number of opioids prescribed. Phone surveys were conducted 4 to 6 weeks after discharge to identify the number of opioids used during the postpartum period. Welch t test was used to determine P values. Results: After exclusion criteria were applied, records of 23 patients with vaginal deliveries and 14 patients with cesarean sections were included in the study. Patients who were prescribed opioids after a vaginal delivery were prescribed signifi-cantly more pills than were used (P<.001); a mean of 10 opioid pills per patient remained unused. Patients prescribed opioids after cesarean section were also often prescribed more opioid pills than used (P<.05); a mean of 7.5 opioid pills per patient remained unused. Of 37 patients, only 2 disposed of unused opioid pills. Conclusion: The data in this study show a clear example of overprescribing opioids after vaginal and cesarean deliveries leading to increased opioid pill availability within the community.
UR - http://www.scopus.com/inward/record.url?scp=85091279181&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091279181&partnerID=8YFLogxK
U2 - 10.7556/jaoa.2020.114
DO - 10.7556/jaoa.2020.114
M3 - Article
AN - SCOPUS:85091279181
SN - 0098-6151
VL - 120
SP - 698
EP - 703
JO - Journal of the American Osteopathic Association
JF - Journal of the American Osteopathic Association
IS - 10
ER -